Mucosal Melanoma: What You Need to Know

While skin cancer is one of the most common types of cancer in the United States, melanoma is the least common type of skin cancer, accounting for less than 1 percent of skin cancer. Unlike most melanomas appearing on visible areas on the skin, mucosal melanoma occurs on the mucus membranes, or moist surfaces, of … Read more

Director of the Lynch Syndrome Center Shares his Personal Connection to Lynch Syndrome

Because of his adopted family’s cancer history, the director of Dana-Farber’s Lynch Syndrome Center, Matt Yurgelun, MD, is uniquely invested in helping patients with Lynch syndrome — a common and often under-diagnosed inherited condition. Eight of the 13 in his grandfather’s generation ultimately developed some form of cancer, and it wasn’t until later that Matt … Read more

Researchers Identify Promising Drug Target in Pediatric Neuroblastoma

Investigators had culled the list of suspects down to two. But which one was the guilty party, or were both? The pair worked together so seamlessly, it was difficult to tell where one’s role began and the other’s ended. In some respects, they even looked alike. Dana-Farber scientists have now teased apart the relationship between … Read more

Providing Emotional Support to Young Patients with Colorectal Cancer

Cancer is a disease that’s often associated with older people; however, a growing number of younger patients are being diagnosed with colorectal cancer. Since the 1990s, the rate of colorectal cancer diagnoses has more than doubled in adults age 20 to 49. Alexa Morell is one of these patients. She didn’t expect her diagnosis: metastatic … Read more

How Does Cancer Start?

Every cancer starts with a mistake deep inside the nucleus of a single cell, where DNA is stored. Abnormalities in DNA can be inherited from one’s parents or can occur because of exposure to harmful substances in the environment such as chemicals in tobacco, ultraviolet radiation from the sun, and perhaps, chemicals in our diet. … Read more

High School Basketball Coach has a New Perspective on Life After a Successful Stem Cell Transplant

For Duane Witter, the most difficult part of his cancer treatment was recovering from his stem cell transplant and having to step away from teaching and coaching high school basketball in Farmington, CT. “Before all this, I used to say that my superpower was to never miss a day of school,” he says. “Stepping away … Read more

Research Sheds More Light on Mechanisms Causing Rare Leukemia BPDCN

A rare leukemia called BPDCN (blastic plasmacytoid dendritic cell neoplasm) is three to four times more common in people with one X chromosome, for reasons that hadn’t been clear. Now, however, research led by Dana-Farber Cancer Institute scientists has identified a genetic factor that appears to explain a large part of the discrepancy, and also … Read more

Prostate Cancer Screening: What You Need to Know

Prostate cancer screening options are available but are not necessarily recommended for all patients. There are positive and negative factors to consider when screening for this cancer, and options should be discussed with a doctor.   Who should be screened for prostate cancer? The U.S. Preventive Services Task Force (USPSTF) recommends that people with prostates … Read more

Pediatric Leukemia Patient Takes LEAP to Remission on Precision Medicine Trial

First Cinthia Roman Manrique learned she had acute lymphoblastic leukemia (ALL). Then the 8-year-old Peru native was uprooted from her school, family, and friends when she flew with her mother in early 2017 to the United States — where chances of a cure for her high-risk cancer were better.  In the U.S., Cinthia’s challenges continued … Read more

For Sisters, Myeloma Study is a Promise Kept

At Carolyn Kershaw and Darlene Musso’s first visit to Dana-Farber in July, Irene Ghobrial, MD, greeted them with some unexpected news. “We walked in and she said, ‘Did you know you two are famous in our lab?’” Kershaw recounts. Their local renown stems from their participation in the PROMISE study at Dana-Farber’s Center for the Prevention of Progression (CPOP), which … Read more

Study Reveals Factors Influencing Success of An Immunotherapy Treatment

Understanding why immunotherapies are highly effective in some patients but fail in many others is one of the top priorities in cancer research — and one of the most challenging puzzles. A research team led by Catherine J. Wu, MD, has uncovered some previously unknown molecular factors affecting donor lymphocyte infusion (DLI), a form of … Read more

Pediatric Patient with Leukemia in Remission after Treatment and Transplant

Rosemary Iwakura, 17, was experiencing strange symptoms before her acute lymphoblastic leukemia diagnosis (ALL) almost two years ago. She was unable to focus on her schoolwork or activities and fainted on several occasions at school and at home. “I thought; ‘People faint for many reasons,’” she recalls. “We weren’t sure if we were supposed to … Read more